People with Painful Diabetic Neuropathy Can Now Receive The Only Spinal Cord Stimulator FDA-Approved for the Condition at Reno-Tahoe Pain Associates
~ Painful diabetic neuropathy causes pain in the limbs, often managed by medicine that is inadequate for long-term relief ~
(RENO, Nev.) – Dr. Ali Nairizi with Reno-Tahoe Pain Associates is now offering the first spinal cord stimulation (SCS) procedure(s) for the treatment of painful diabetic neuropathy (PDN). The technology is a newly approved nondrug treatment for PDN, and is the only SCS system with a specific indication to treat the condition.
Nairizi, a board-certified interventional pain specialist, is one of only a few physicians locally offering the new treatment to provide patients suffering from chronic pain due to post-chemotherapy, diabetes and other illnesses.
“The Senza device is a game-changer for patients with chronic, stabbing and shooting pain,” said Dr. Ali Nairizi. “With this simple procedure, we can provide nearly immediate relief that reduces or eliminates the reliance narcotics such as opioids.”
More than 34 million people in the U.S. have diabetes, and it’s estimated that 20-25% of people with diabetes will develop PDN. The condition is associated with a wide range of symptoms including pain in the limbs described as burning, freezing, stabbing, shooting, hypersensitivity or deep aching.
Traditional treatment options for PDN include over-the-counter medications, prescription medications, physical therapy and injections, but for many people, these options are inadequate for long-term relief.
HFX for PDN is the only spinal cord stimulation system approved by the Food and Drug Administration (FDA) with a specific indication for PDN. HFX is a comprehensive solution that includes a Senza spinal cord stimulation system and support services for the treatment of chronic pain. HFX for PDN means that a patient has been implanted with a Senza System and programmed to include a frequency of 10 kHz.
The Senza device is implanted during a quick and minimally invasive procedure, and then begins delivering mild pulses at a high frequency directly to the spinal cord to stop pain signals from reaching the brain. In a recent study, 92% of patients reported high satisfaction with the therapy.
“People with PDN know it to be a cruel addition to the chronic disease they must fight every day,” said Nairizi, MD. “HFX for PDN offers a new option to alleviate this agonizing and persistent sensation. There is no other therapy like this, and to offer it to people here in northern Nevada is an absolute privilege. I believe this can make a real difference for the patients we treat who suffer from PDN.”
For important safety information regarding this new treatment, please visit www.HFXforPDN.com. For more information about the procedure or Reno-Tahoe Pain Associates, visit our website at https://www.renotahoepain.com/
Dr. Nairizi is a Board-Certified Interventional Pain Specialist and Anesthesiologist who is dedicated to treating patients with a wide array of chronic pain conditions, such as back, neck, shoulder, hip and knee pain. He is very passionate about his patients and his goal is to provide them with the best care possible. He believes that a comprehensive and multidisciplinary approach that is tailored to the patient’s needs provides the best results. He also understands that successful treatment of painful conditions depends on identifying the underlying cause for the pain, not just masking it.
Tiffany East, APR
# # #
 CDC 2020 National Diabetes Statistics
 Schmader KE et al. Clin J Pain. 2002;18(6):350-354
 Peltier A, et al. BMJ. 2014;348g1799.
 Petersen EA, et al. JAMA Neurol. Published online April 05, 2021. doi:10.1001/jamaneurol.2021.0538